Dr. Chris?Lorenc?is a technical specialist in the Intellectual Property group in the?firms?Boston office. His work involves patent prosecution in the Life Sciences, including biotechnology and pharmaceuticals, small molecules, and chemistry. Chris was a postdoctoral research scientist with Jack Norton at Columbia University where his research involved replacing tin hydrides in pharmaceutically useful radical cyclization reactions with cobalt and vanadium complexes using hydrogen gas.